Abstract
Implantation of cardioverter-defibrillator system is necessary and it needs to be performed as soon as possible in patients with secondary sudden cardiac death prevention including resynchronization therapy indications. Patients on active immunosuppressive treatment are at the highest risk of infective complications of every kind of surgical intervention. In the case of cardiac implantable devices implementation of an antibacterial envelope could be a relevant factor in infective risk prevention.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
